Intervention Review

Drug treatment for facioscapulohumeral muscular dystrophy

  1. Michael R Rose1,*,
  2. Rabi Tawil2

Editorial Group: Cochrane Neuromuscular Group

Published Online: 19 APR 2004

Assessed as up-to-date: 9 JAN 2004

DOI: 10.1002/14651858.CD002276.pub2

How to Cite

Rose MR, Tawil R. Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002276. DOI: 10.1002/14651858.CD002276.pub2.

Author Information

  1. 1

    King's College Hospital, Department of Neurology, London, UK

  2. 2

    University of Rochester School of Medicine and Dentistry, Neuromuscular Disease Center, Rochester, New York, USA

*Michael R Rose, Department of Neurology, King's College Hospital, Academic Neuroscience Centre, Denmark Hill, London, SE5 9RS, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.